Cefazolin.
D000617:Aminoglycosides / Q000009:adverse effects; D000818:Animals; D001419:Bacteria / Q000187:drug effects* / Q000201:enzymology; D002437:Cefazolin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D002510:Cephalosporinase / Q000096:biosynthesis; D002511:Cephalosporins / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D011817:Rabbits; D051381:Rats; D013045:Species Specificity
D000617:Aminoglycosides; D002511:Cephalosporins; D002510:Cephalosporinase; D002437:Cefazolin